Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Biallelic CYP24A1 variants presenting during pregnancy: Clinical and biochemical phenotypes

Lookup NU author(s): Sumaya Alkanderi, Professor John SayerORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Abstract

© 2020 the authors.Introduction: Inactivating mutations in CYP24A1, encoding vitamin D-24-hydroxylase, can lead to an accumulation of active vitamin D metabolites and consequent hypercalcaemia. Patient (infantile and adult) presentation is varied and includes mild-severe hypercalcaemia, hypercalciuria, nephrocalcinosis and nephrolithiasis. This study aimed to characterize the clinical and biochemical phenotypes of a family with two CYP24A1 missense variants. Methods: The proband and seven family members underwent detailed clinical and biochemical evaluation. Laboratory measurements included serum calcium, intact parathyroid hormone (iPTH), vitamin D metabolites and urine calcium and creatinine. Results: The proband presented during the second trimester of a planned pregnancy with flu-like symptoms. Laboratory tests showed elevated adjusted calcium of 3.27 (upper reference limit (URL: 2.30) mmol/L), suppressed iPTH (<6 ng/L), elevated 25(OH)D (264 (URL: 55) nmol/L) and elevated 1,25(OH)D (293 (URL: <280) pmol/L). Ionized calcium was 1.55 (URL: 1.28) mmol/L. Sanger sequencing revealed two heterozygous missense variants in the CYP24A1: p.(Arg439Cys), R439C and p.(Trp275Arg), W275R. The proband’s brother and sister had the same genotype. The brother had intermittent hypercalcaemia and hypervitaminosis D. Only the sister had a history of nephrolithiasis. The proband’s daughter and two nephews were heterozygous for the R439C variant. The proband and her brother frequently had elevated 25(OH)D:24,25(OH)2 D ratios (>50) during follow-up. Conclusions: W275R is a new pathogenic CYP24A1 mutation in compound heterozygotic form with R439C in this family.


Publication metadata

Author(s): Griffin TP, Joyce CM, Alkanderi S, Blake LM, O'Keeffe DT, Bogdanet D, Islam MN, Dennedy MC, Gillan JE, Morrison JJ, O'Brien T, Sayer JA, Bell M, O'Shea PM

Publication type: Article

Publication status: Published

Journal: Endocrine Connections

Year: 2020

Volume: 9

Issue: 6

Pages: 530-541

Print publication date: 01/06/2020

Online publication date: 06/05/2020

Acceptance date: 06/05/2020

Date deposited: 02/07/2020

ISSN (electronic): 2049-3614

Publisher: BioScientifica Ltd.

URL: https://doi.org/10.1530/EC-20-0150

DOI: 10.1530/EC-20-0150


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
J A S is supported by Kidney Research UK and the Northern Counties Kidney Research Fund.

Share